Late-onset CblC Defect: Clinical, Biochemical and Molecular Analysis

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2023 Sep 28

PMID 37770946

Authors

Si Ding

Shiying Ling

Lili Liang

Wenjuan Qiu

Huiwen Zhang

Ting Chen

Xia Zhan

Feng Xu

Xuefan Gu

Lianshu Han

Affiliations

Soon will be listed here.

Abstract

Background: cblC defect is the most common type of methylmalonic acidemia in China. Patients with late-onset form (>1 year) are often misdiagnosed due to heterogeneous symptoms. This study aimed to describe clinical characteristics and evaluate long-term outcomes of Chinese patients with late-onset cblC defect.

Methods: A total of 85 patients with late-onset cblC defect were enrolled. Clinical data, including manifestations, metabolites, molecular diagnosis, treatment and outcome, were summarized and analyzed.

Results: The age of onset ranged from 2 to 32.8 years old (median age 8.6 years, mean age 9.4 years). The time between first symptoms and diagnosis ranged from a few days to 20 years (median time 2 months, mean time 20.7 months). Neuropsychiatric symptoms were presented as first symptoms in 68.2% of cases, which were observed frequently in schoolchildren or adolescents. Renal involvement and cardiovascular disease were observed in 20% and 8.2% of cases, respectively, which occurred with the highest prevalence in preschool children. Besides the initial symptoms, the disease progressed in most patients and cognitive decline became the most frequent symptom overall. The levels of propionylcarnitine, propionylcarnitine / acetylcarnitine ratio, methylmalonic acid, methylcitric acid and homocysteine, were decreased remarkably after treatment (P<0.001). Twenty-four different mutations of MMACHC were identified in 78 patients, two of which were novel. The c.482G>A variant was the most frequent mutated allele in this cohort (25%). Except for 16 patients who recovered completely, the remaining patients were still left with varying degrees of sequelae in a long-term follow-up. The available data from 76 cases were analyzed by univariate analysis and multivariate logistic regression analysis, and the results showed that the time from onset to diagnosis (OR = 1.025, P = 0. 024) was independent risk factors for poor outcomes.

Conclusions: The diagnosis of late-onset cblC defect is often delayed due to poor awareness of its various and nonspecific symptoms, thus having an adverse effect on the prognosis. It should be considered in patients with unexplained neuropsychiatric and other conditions such as renal involvement, cardiovascular diseases or even multiple organ damage. The c.482G>A variant shows the highest frequency in these patients. Prompt treatment appears to be beneficial.

Citing Articles

Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes.

Hao L, Ling S, Ding S, Qiu W, Zhang H, Zhang K Pediatr Res. 2024; .

PMID: 39306609 DOI: 10.1038/s41390-024-03581-x.

Concurrent combined methylmalonic acidemia and homocystinuria with down syndrome in a Chinese preschool Child: An in-depth case report and literature review.

Dong R, Liu C, Liu Y, Zhang H, Liu G, Liu Y Heliyon. 2024; 10(13):e33457.

PMID: 39027567 PMC: 11255855. DOI: 10.1016/j.heliyon.2024.e33457.

The utility of methylmalonic acid, methylcitrate acid, and homocysteine in dried blood spots for therapeutic monitoring of three inherited metabolic diseases.

Liu Y, Ma X, Kang L, Jin Y, Li M, Song J Front Nutr. 2024; 11:1414681.

PMID: 38966413 PMC: 11222987. DOI: 10.3389/fnut.2024.1414681.

References

Heringer J, Valayannopoulos V, Lund A, Wijburg F, Freisinger P, Baric I . Impact of age at onset and newborn screening on outcome in organic acidurias. J Inherit Metab Dis. 2015; 39(3):341-353. DOI: 10.1007/s10545-015-9907-8. View

Lerner-Ellis J, Tirone J, Pawelek P, Dore C, Atkinson J, Watkins D . Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet. 2005; 38(1):93-100. DOI: 10.1038/ng1683. View

Weisfeld-Adams J, Bender H, Miley-Akerstedt A, Frempong T, Schrager N, Patel K . Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013; 110(3):241-7. DOI: 10.1016/j.ymgme.2013.07.018. View

Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist J . Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2016; 40(1):21-48. PMC: 5203859. DOI: 10.1007/s10545-016-9991-4. View

Almannai M, Marom R, Divin K, Scaglia F, Sutton V, Craigen W . Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. Mol Genet Metab. 2017; 122(1-2):60-66. PMC: 5612879. DOI: 10.1016/j.ymgme.2017.06.011. View

Almasi T, Guey L, Lukacs C, Csetneki K, Voko Z, Zelei T . Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Orphanet J Rare Dis. 2019; 14(1):84. PMC: 6485056. DOI: 10.1186/s13023-019-1063-z. View

Roehrs C, Garrido-Sanabria E, Da Silva A, Faria L, Sinhorin V, Marques R . Succinate increases neuronal post-synaptic excitatory potentials in vitro and induces convulsive behavior through N-methyl-d-aspartate-mediated mechanisms. Neuroscience. 2004; 125(4):965-71. DOI: 10.1016/j.neuroscience.2004.01.058. View

Liu Y, Liu Y, Zhang Y, Song J, Zheng H, Dong H . [Heterogeneous phenotypes, genotypes, treatment and prevention of 1 003 patients with methylmalonic acidemia in the mainland of China]. Zhonghua Er Ke Za Zhi. 2018; 56(6):414-420. DOI: 10.3760/cma.j.issn.0578-1310.2018.06.003. View

Ogier de Baulny H, Gerard M, Saudubray J, Zittoun J . Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr. 1998; 157 Suppl 2:S77-83. DOI: 10.1007/pl00014307. View

10.

Huemer M, Baumgartner M . The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways. J Inherit Metab Dis. 2019; 42(4):686-705. DOI: 10.1002/jimd.12012. View

11.

Lerner-Ellis J, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M . Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat. 2009; 30(7):1072-81. DOI: 10.1002/humu.21001. View

12.

Zhou W, Li H, Wang C, Wang X, Gu M . Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations. Front Genet. 2019; 9:726. PMC: 6351470. DOI: 10.3389/fgene.2018.00726. View

13.

Ryckman K, Berberich S, Shchelochkov O, Cook D, Murray J . Clinical and environmental influences on metabolic biomarkers collected for newborn screening. Clin Biochem. 2012; 46(1-2):133-8. PMC: 3534803. DOI: 10.1016/j.clinbiochem.2012.09.013. View

14.

Hong F, Huang X, Zhang Y, Yang J, Tong F, Mao H . [Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017; 46(3):240-247. PMC: 10397097. DOI: 10.3785/j.issn.1008-9292.2017.06.03. View

15.

Wang C, Li D, Cai F, Zhang X, Xu X, Zhang C . Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review. Eur J Med Genet. 2019; 62(10):103713. DOI: 10.1016/j.ejmg.2019.103713. View

16.

Hori D, Hasegawa Y, Kimura M, Yang Y, Verma I, Yamaguchi S . Clinical onset and prognosis of Asian children with organic acidemias, as detected by analysis of urinary organic acids using GC/MS, instead of mass screening. Brain Dev. 2005; 27(1):39-45. DOI: 10.1016/j.braindev.2004.04.004. View

17.

Zhou J, Austin R . Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors. 2009; 35(2):120-9. DOI: 10.1002/biof.17. View

18.

Powers J, Rosenblatt D, Schmidt R, Cross A, Black J, Moser A . Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol. 2001; 49(3):396-400. View

19.

Gu X, Wang Z, Ye J, Han L, Qiu W . Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singap. 2009; 37(12 Suppl):107-4. View

20.

E H, Liang L, Zhang H, Qiu W, Ye J, Xu F . Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients From China. Front Genet. 2021; 12:702374. PMC: 8293753. DOI: 10.3389/fgene.2021.702374. View